CBLN1 and cholestasis: We found that cholestasis upregulates ACER3, while ACER3 ablation promotes the binding of CER(d18:1/18:1) to LXRβ to activate LXRβ signaling, thereby improving BA detoxification and lipogenesis to attenuate CLI.